Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-007741
Filing Date
2017-12-19
Accepted
2017-12-19 10:09:23
Documents
4
Period of Report
2018-01-12
Effectiveness Date
2017-12-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2234092zdef14a.htm DEF 14A 312507
2 G530771.JPG g530771.jpg GRAPHIC 16252
3 G281842BGI001.GIF g281842bgi001.gif GRAPHIC 130135
4 G281842BGI002.GIF g281842bgi002.gif GRAPHIC 91103
  Complete submission text file 0001047469-17-007741.txt   641074
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37990 | Film No.: 171263038
SIC: 2834 Pharmaceutical Preparations